Statistics for Emicizumab is well tolerated and effective in people with congenital haemophila A regardless of age severity of disease or inhibitor status a scoping review
Total visits
| views | |
|---|---|
| Emicizumab is well tolerated and effective in people with congenital haemophila A regardless of age severity of disease or inhibitor status a scoping review | 1 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 1 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Journal Article.pdf | 2 |
Top country views
| views | |
|---|---|
| Norway | 1 |
Top city views
| views | |
|---|---|
| Oslo | 1 |